Sabrina Jamieson
Psychiatry · Plymouth, MINPI 1184405722
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $844, more than ten times the $33 reported in 2023.
Across 86 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$194
- Novo Nordisk$182
- ANI Pharmaceuticals, Inc.$157
- Boehringer Ingelheim$119
- Lilly USA, LLC$98
- GSK$90
- plus $834 from 21 others
What the payments were for
- Food & beverage$1,675100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $194 |
| Novo Nordisk | 11 | $182 |
| ANI Pharmaceuticals, Inc. | 7 | $157 |
| Boehringer Ingelheim | 6 | $119 |
| Lilly USA, LLC | 6 | $98 |
| GSK | 5 | $90 |
| Xeris Pharmaceuticals, Inc. | 2 | $76 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $73 |
| Verity Pharmaceuticals Inc. | 3 | $62 |
| Pfizer | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Exact Sciences | 3 | $55 |
| Shield Therapeutics Inc | 3 | $51 |
| AstraZeneca | 3 | $49 |
| Astellas Pharma US Inc | 3 | $46 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Antares Pharma, Inc. | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Merck | 1 | $29 |
| Alkermes, Inc. | 1 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Tolmar, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Amgen | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
How this compares
$1,675 in reported general payments places this provider in the 80th percentile of 1,166 psychiatry providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 54 | $1,598 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $911 |
| Losartan Potassium | 34 | $605 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 62 | $584 |
| Rosuvastatin Calcium | 27 | $566 |
| Montelukast Sodium | 21 | $365 |
| Methylprednisolone | 59 | $333 |
| CefuroximeCefuroxime Axetil | 34 | $327 |
| Atorvastatin Calcium | 21 | $284 |
| Azithromycin | 62 | $257 |
| Sertraline Hcl | 13 | $250 |
| Gabapentin | 18 | $183 |
| Metformin Hcl | 16 | $160 |
| Trazodone Hcl | 20 | $146 |
| Omeprazole | 11 | $123 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Plymouth
- Robert ZoltowskiPlymouth$12K
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
- Michael IngramBay City$255K
- Samuel WedesLivonia$158K
- Arash JavanbakhtDetroit$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.